Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
07:16pm, Thursday, 26'th Feb 2026
Medpace (MEDP) reached $447.09 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
Citizens Business Bank Acquires Shares of 1,790 Medpace Holdings, Inc. $MEDP
04:47am, Thursday, 26'th Feb 2026
Citizens Business Bank bought a new position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange C
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates
12:10am, Monday, 23'rd Feb 2026
New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: ME
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
09:00am, Wednesday, 18'th Feb 2026
(NASDAQ: MEDP) NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Medpace Holdings, Inc. (NASDAQ: MEDP) concerning potential securities law claims on behalf of shareholders
Pre-Market Stock Futures: Futures are trading higher after a sluggish start to the holiday-shortened trading week. While stocks started as if it were going to be another risk-off day, they turned posi
Lost Investment in Medpace Holdings, Inc. (MEDP)? Levi & Korsinsky Launches Securities Fraud Investigation
04:26pm, Tuesday, 17'th Feb 2026
New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Medpace Holdings, Inc. ("Medpace Holdings, Inc.") (NASDAQ: ME
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
01:30pm, Monday, 16'th Feb 2026
Large, sudden stock price swings—like Medpace's recent spike and drop—are often driven by identifiable factors such as short squeezes or concentrated trading, not pure randomness. Investors should
Pinterest, DraftKings, and Astera Labs led last week's large-cap losers as cautious outlooks and post-earnings guidance/downgrades sparked a broad pullback across tech, housing, and gaming names.
Cibc World Market Inc. Makes New $5.03 Million Investment in Medpace Holdings, Inc. $MEDP
04:43am, Sunday, 15'th Feb 2026
Cibc World Market Inc. acquired a new position in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) in the undefined quarter, according to the company in its most recent disclosure with the Securities a
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial
02:00am, Wednesday, 11'th Feb 2026
Oslo, Norway – 11 February 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid canc
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
12:04pm, Tuesday, 10'th Feb 2026
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
The 'Key Negative' That Took Out Medpace's Sales, Profit Beat
09:29am, Tuesday, 10'th Feb 2026
Medpace stock slumped early Tuesday on a "significant bookings miss," outshining the company's solid fourth-quarter sales and earnings.
Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation
10:58pm, Monday, 09'th Feb 2026
Medpace Holdings delivered strong Q4 and FY 2025 results, beating revenue and EPS expectations, with 32% YoY revenue growth and 27% YoY EPS growth. MEDP's backlog growth remains sluggish, but a health
Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates
06:26pm, Monday, 09'th Feb 2026
Medpace (MEDP) came out with quarterly earnings of $4.67 per share, beating the Zacks Consensus Estimate of $4.18 per share. This compares to earnings of $3.67 per share a year ago.
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
04:15pm, Monday, 09'th Feb 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 F
